This study identifies MAP3K8-driven MEK-ERK signaling as a key pathway in HTLV-1-associated myelopathy (HAM) and reveals virus-induced chromatin remodeling as its molecular basis, highlighting MAP3K8 as a promising therapeutic target.
- Makoto Nakashima
- Kaho Nagai
- Yoshihisa Yamano
